Number of the records: 1  

Discovery of varlaxins, new aeruginosin-type inhibitors of human trypsins

  1. 1.
    SYSNO ASEP0556382
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleDiscovery of varlaxins, new aeruginosin-type inhibitors of human trypsins
    Author(s) Heinila, L. (FI)
    Jokela, J. (FI)
    Ahmed, M. (FI)
    Wahlsten, M. (FI)
    Saurav, Kumar (MBU-M) ORCID
    Hrouzek, Pavel (MBU-M) ORCID
    Permi, P. (FI)
    Koistinen, H. (FI)
    Fewer, D. (FI)
    Sivonen, K. (FI)
    Source TitleOrganic & Biomolecular Chemistry. - : Royal Society of Chemistry - ISSN 1477-0520
    Roč. 20, č. 13 (2022), s. 2681-2692
    Number of pages12 s.
    Languageeng - English
    CountryGB - United Kingdom
    Keywordsbiosynthetic gene-cluster ; nostoc sp ; identification ; evolution ; 298-a ; prss3/mesotrypsin ; microcystis ; expression ; resistance ; peptides
    Subject RIVCC - Organic Chemistry
    OECD categoryOrganic chemistry
    Method of publishingOpen access
    Institutional supportMBU-M - RVO:61388971
    UT WOS000769605700001
    EID SCOPUS85127631800
    DOI10.1039/d1ob02454j
    AnnotationLow-molecular weight natural products display vast structural diversity and have played a key role in the development of novel therapeutics. Here we report the discovery of novel members of the aeruginosin family of natural products, which we named varlaxins. The chemical structures of varlaxins 1046A and 1022A were determined using a combination of mass spectrometry, analysis of one- and two-dimensional NMR spectra, and HPLC analysis of Marfey's derivatives. These analyses revealed that varlaxins 1046A and 1022A are composed of the following moieties: 2-O-methylglyceric acid 3-O-sulfate, isoleucine, 2-carboxy-6-hydroxyoctahydroindole (Choi), and a terminal arginine derivative. Varlaxins 1046A and 1022A differ in the cyclization of this arginine moiety. Interestingly, an unusual alpha-d-glucopyranose moiety derivatized with two 4-hydroxyphenylacetic acid residues was bound to Choi, a structure not previously reported for other members of the aeruginosin family. We sequenced the complete genome of Nostoc sp. UHCC 0870 and identified the putative 36 kb varlaxin biosynthetic gene cluster. Bioinformatics analysis confirmed that varlaxins belong to the aeruginosin family of natural products. Varlaxins 1046A and 1022A strongly inhibited the three human trypsin isoenzymes with IC50 of 0.62-3.6 nM and 97-230 nM, respectively, including a prometastatic trypsin-3, which is a therapeutically relevant target in several types of cancer. These results substantially broaden the genetic and chemical diversity of the aeruginosin family and provide evidence that the aeruginosin family is a source of strong inhibitors of human serine proteases.
    WorkplaceInstitute of Microbiology
    ContactEliška Spurná, eliska.spurna@biomed.cas.cz, Tel.: 241 062 231
    Year of Publishing2023
    Electronic addresshttps://pubs.rsc.org/en/content/articlelanding/2022/OB/D1OB02454J
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.